South Korea Interventional Cardiology Devices Market Size & Outlook

The interventional cardiology devices market in South Korea is expected to reach a projected revenue of US$ 588.4 million by 2030. A compound annual growth rate of 8.3% is expected of South Korea interventional cardiology devices market from 2024 to 2030.
Revenue, 2023 (US$M)
$336.2
Forecast, 2030 (US$M)
$588.4
CAGR, 2024 - 2030
8.3%
Report Coverage
South Korea

South Korea interventional cardiology devices market, 2018-2030 (US$M)

South

Related Markets

South Korea interventional cardiology devices market highlights

  • The South Korea interventional cardiology devices market generated a revenue of USD 336.2 million in 2023 and is expected to reach USD 588.4 million by 2030.
  • The South Korea market is expected to grow at a CAGR of 8.3% from 2024 to 2030.
  • In terms of segment, coronary stents was the largest revenue generating product in 2023.
  • Accessory Devices is the most lucrative product segment registering the fastest growth during the forecast period.


Interventional cardiology devices market data book summary

Market revenue in 2023USD 336.2 million
Market revenue in 2030USD 588.4 million
Growth rate8.3% (CAGR from 2023 to 2030)
Largest segmentCoronary stents
Fastest growing segmentAccessory Devices
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationIntravascular Imaging Catheters and Pressure Guidewires, Coronary Stents, PTCA Balloon Catheters, Accessory Devices
Key market players worldwideAbbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol


Other key industry trends

  • In terms of revenue, South Korea accounted for 3.4% of the global interventional cardiology devices market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China interventional cardiology devices market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 936.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Interventional Cardiology Devices Market Companies

Name Profile # Employees HQ Website

South Korea interventional cardiology devices market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional cardiology devices market will help companies and investors design strategic landscapes.


Coronary stents was the largest segment with a revenue share of 51.37% in 2023. Horizon Databook has segmented the South Korea interventional cardiology devices market based on intravascular imaging catheters and pressure guidewires, coronary stents, ptca balloon catheters, accessory devices covering the revenue growth of each sub-segment from 2018 to 2030.


Abbott Laboratories, Boston Scientific Corporation, Cardinal Health Inc., and Medtronic PLC are some key players in South Korea. These companies contribute to market growth by providing a wide range of innovative devices and solutions to meet the evolving needs of healthcare providers and patients in the country.

In addition, South Korea has experienced a significant increase in life expectancy due to advancements in healthcare, improved living standards, and public health initiatives. As people live longer, they are more likely to develop age-related cardiovascular conditions, driving the demand for interventional cardiology devices to the market to manage these health issues.

Furthermore, a May 2023 NIH study, predicting the 10-year risk of atherosclerotic cardiovascular disease in South Korea, revealed 4,367 Atherosclerotic CVD (ASCVD) events over a decade. This data underscores the demand for interventional cardiology devices, driving market growth to address cardiovascular health needs effectively in the country.

Reasons to subscribe to South Korea interventional cardiology devices market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Korea interventional cardiology devices market databook

  • Our clientele includes a mix of interventional cardiology devices market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Korea interventional cardiology devices market , including forecasts for subscribers. This country databook contains high-level insights into South Korea interventional cardiology devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Korea interventional cardiology devices market size, by product, 2018-2030 (US$M)

South Korea Interventional Cardiology Devices Market Outlook Share, 2023 & 2030 (US$M)

South Korea interventional cardiology devices market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more